Summary. The effects of PGI-salt and PGI-2 methyl ester on intrauterine pressure (IUP) and uterine electromyographic activity (EMG) were examined in vivo in non-pregnant ovariectomized sheep. PGI-2 salt and PGI-2 methyl ester (50\p=n-\200\ g=m\ g) reduced significantly the frequency and amplitude of IUP cycles and also inhibited the associated uterine EMG activity. Injections of oxytocin (50 mU) or (2 \g=m\g)partly overcame the inhibition of IUP induced by the PGI-2 methyl ester.
Introduction
Prostacyclin (PGI-2) is a potent inhibitor of platelet aggregation and it relaxes vascular smooth muscle (Moneada, Gryglewski, Bunting & Vane, 1976;  Armstrong, Dusting, Moneada & Vane, 1978) . Several investigators have shown that PGI-2 is present in the myometrium of pregnant and non-pregnant animals and in women (Jones, Poyser & Wilson, 1977; Dembinska-kiec, Zmuda & Gryglewski, 1978; Omini, Folco, Pasargiklian, Fano & Berti, 1979) . PGI-2 is also produced in the human placenta (Myatt & Elder, 1977) and in the fetal membranes (Satoh et al, 1981) . PGI-2 may be involved in the inhibition of uterine activity during pregnancy (Thorburn & Challis, 1979) , but in-vitro experiments have provided conflicting results. Omini, Pasargiklian, Folco, Fano & Berti (1978) showed that PGI-2 inhibited spontaneous and PGF-2a induced contractile activity in strips of human myometrium in vitro and this inhibition was correlated (Omini et al, 1979) with an increase in the accumulation of cyclic AMP in the tissues. In contrast Williams, El-Tahir & Marcinkiewicz (1979) demonstrated that, in the rat, PGI-2 stimulated myometrial activity in vitro. In view of this apparent conflict we have examined the effects of PGI-2 on the mechanical and electrical activity of the sheep uterus, but using in-vivo procedures.
that its tip lay in the abdominal aorta 6-10 cm above the origin of the uterine artery. The animals received 50 µg oestradiol-17ß s.c. for 5 days after surgery. Oestradiol was then withdrawn to establish a pattern of continuous spontaneous activity (Porter, 1979 an aliquant (0-1 ml) containing 50, 100 or 200 µg PGI-2 was added to 5 ml saline (9 g NaCl/1).
Within 30 sec of dilution the material was injected through the femoral arterial catheter over a period of 90 sec. Synthetic oxytocin (50 mU/0-25 ml saline; Armitage Carroll, London, Ontario, Canada) or PGF-2a (2 µg/0·2 ml saline; Lutalyse: Upjohn) were administered through the femoral arterial catheter. The frequency and maximum amplitude of intrauterine pressure cycles were analysed in 5-min periods as described previously (Lye & Porter, 1978) . Results are expressed as mean ± s.e.m. for 4 sheep. The effects of PGI-2 on uterine activity were assessed using Duncan's multiple range test (Snedecor, 1956 fell from 6-1 ± 0-4 and 4-0 ± 0-23 cycles/5 min before injection to 0-25 ± 0-25 and 0-5 ±0-5 cycles/5 min at 5 min after PGI-2 methyl ester and PGI-2 salt respectively (both < 0-001),
and remained significantly below preinjection values for about 60 min ( < 0-05). The mean maximum amplitude of intrauterine pressure cycles fell from preinjection values of 35-6 ± 1-9 and 27-3 ± 1-3 mmHg to 2-8 ± 2-8 and 4-0 ± 4-0 mmHg at 5 min after PGI-2 methyl ester and PGI-2 salt respectively (both < 0-001 (Jones et al, 1977; Omini et al, 1979; Abel & Kelly, 1979; Evans, Kennedy, Patrick & Challis, 1981) . Our results show a marked inhibitory action of PGI-2 on myometrial activity in vivo. This action is similar to the inhibitory effects of PGI-2 on human myometrial strips in vitro (Omini et al, 1978) . It is striking that the onset of effect was equally rapid after the methyl ester and the salt, suggesting that the inhibitory action is unlikely to be due to the formation of a metabolite of PGI-2, although we cannot exclude this possibility. The concurrent inhibition of electrical as well as of mechanical activity might suggest that the PGI-2 action is primarily at the level of the myometrium rather than being mediated indirectly through changes in blood flow (Clark, Austin &Stys, 1981) .
We are unable to assess the physiological significance of the amounts of PGI-2 used in these studies, because the majority of the injected material would probably be diverted through the common iliac arteries, and we did not measure the proportion of the injected material that reached the uterus. However, our results raise the possibility that in some species, such as sheep and women, endogenous PGI-2 of uterine origin may be an inhibitor of myometrial activity in different states, including pregnancy. Our results suggest that such an inhibition might be overcome by oxytocin or PGF-2a at term, either as the production of these agonists increases, or as a result of a change in uterine responsiveness (Thorburn & Challis, 1979) .
